Department of Gastroenterology & Hepatology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands.
Fam Cancer. 2022 Jan;21(1):49-56. doi: 10.1007/s10689-020-00225-x. Epub 2021 Jan 19.
Lynch syndrome is the most frequent hereditary colorectal cancer (CRC) syndrome, affecting approximately 1 in 300 in the Western population. It is caused by pathogenic variants in the mismatch repair (MMR) genes including MLH1, MSH2 (EPCAM), MSH6 and PMS2, and is associated with high risks of CRC, endometrial cancer and other cancers. In view of these risks, carriers of such variants are encouraged to participate in colonoscopic surveillance programs that are known to substantially improve their prognosis. In the last decade several important studies have been published that provide detailed cancer risk estimates and prognoses based on large numbers of patients. These studies also provided new insights regarding the pathways of carcinogenesis in CRC, which appear to differ depending on the specific MMR gene defect. In this report, we will discuss the implications of these new findings for the development of new surveillance protocols.
林奇综合征是最常见的遗传性结直肠癌(CRC)综合征,在西方人群中约每 300 人中有 1 人受到影响。它是由错配修复(MMR)基因中的致病性变异引起的,包括 MLH1、MSH2(EPCAM)、MSH6 和 PMS2,并且与 CRC、子宫内膜癌和其他癌症的高风险相关。鉴于这些风险,鼓励此类变异的携带者参与结肠镜监测计划,这些计划已被证明可大大改善其预后。在过去的十年中,已经发表了几项重要的研究,这些研究基于大量患者提供了详细的癌症风险估计和预后。这些研究还提供了关于 CRC 中致癌途径的新见解,这些途径似乎取决于特定的 MMR 基因缺陷。在本报告中,我们将讨论这些新发现对新监测方案的制定的影响。